• TechCrunch
• CrunchBase
• More
  • TechCrunch Europe
  • TechCrunch France
  • TechCrunch Japan

Aphelion Capital

edit

Aphelion Capital is a venture capital firm focused on supporting the growth of innovative medical technology with an emphasis on fast to market, low capital intense products that reduce the cost of delivering quality healthcare.

They leverage their considerable knowledge and deep networks to accelerate commercial success of a company. Their team has extensive experience investing in healthcare companies across both the private and public equity markets.

Milestones

edit

• 
  Aphelion Capital invested in Clear Catheter Systems. (2/9/12)
  Posted 2/9/12 at 3:15am via onbiovc.com
• 
  Aphelion Capital invested in CytoPherx. (1/4/12)
  Posted 1/4/12 at 10:07pm via finsmes.com
• 
  Aphelion Capital invested in Clear Catheter Systems. (12/29/11)
  Posted 12/31/11 at 3:25am via marketwatch.com
• 
  Aphelion Capital invested in Corium International. (9/26/07)
  Posted 3/11/10 at 11:55pm via coriumgroup.com

Investments

Videos

Sources

1. Clear Catheter Systems, Inc.: Series C $4.9M (onbiovc.com) [edit]
2. CytoPherx Completes $34M Funding (finsmes.com) [edit]
3. Clear Catheter Systems Raises $4 Million in VC Funding (marketwatch.com) [edit]
4. Corium International, Inc., Announces $40 Million Financing led by Essex Woodlands Health Ventures (coriumgroup.com) [edit]